Literature DB >> 12213226

Toluene inhibits voltage-sensitive calcium channels expressed in pheochromocytoma cells.

Riddick Tillar1, Timothy J Shafer, John J Woodward.   

Abstract

Commercial solvents such as toluene are commonly used as drugs of abuse by children and adolescents. The cellular and molecular sites and mechanisms of actions of these compounds are not well studied but their effects on behavior resemble those of central nervous system depressants such as alcohol, barbiturates and benzodiazepines. In this study, the effects of toluene on voltage-sensitive calcium channels (VSCCs) were measured in pheochromocytoma cells. The KCl-induced rise in intracellular calcium as measured by calcium imaging was almost completely blocked by the dihydropyridine calcium channel antagonist nifedipine verifying that undifferentiated pheochromocytoma cells express mainly the L-type of calcium channel. Toluene (0.3-3000 microM) by itself did not affect intracellular calcium levels in resting cells but dose-dependently inhibited the KCl-induced rise in calcium. This inhibition was substantially reversed upon washout of the toluene-containing solution. KCl-dependent increases in intracellular calcium in cells differentiated with nerve growth factor (NGF) were largely insensitive to nifedipine. Toluene produced a greater inhibition of the KCl response in NGF treated cells as compared with undifferentiated cells. A similar finding was obtained when whole-cell patch-clamp-electrophysiology was used to directly monitor the effects of toluene on voltage-activated calcium currents in undifferentiated and differentiated cells. These results show that dihydropyridine sensitive and insensitive calcium channels are inhibited by toluene and may represent important sites of action for this compound.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12213226     DOI: 10.1016/s0197-0186(02)00048-7

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  9 in total

1.  Review of toluene action: clinical evidence, animal studies and molecular targets.

Authors:  Silvia L Cruz; María Teresa Rivera-García; John J Woodward
Journal:  J Drug Alcohol Res       Date:  2014

Review 2.  Effects of toxic environmental contaminants on voltage-gated calcium channel function: from past to present.

Authors:  William D Atchison
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945

Review 3.  The PC12 cell as model for neurosecretion.

Authors:  R H S Westerink; A G Ewing
Journal:  Acta Physiol (Oxf)       Date:  2007-11-15       Impact factor: 6.311

4.  Editor's Highlight: Genetic Targets of Acute Toluene Inhalation in Drosophila melanogaster.

Authors:  Philip J Bushnell; William O Ward; Tatiana V Morozova; Wendy M Oshiro; Mimi T Lin; Richard S Judson; Susan D Hester; John M McKee; Mark Higuchi
Journal:  Toxicol Sci       Date:  2017-03-01       Impact factor: 4.849

Review 5.  Volatile solvents as drugs of abuse: focus on the cortico-mesolimbic circuitry.

Authors:  Jacob T Beckley; John J Woodward
Journal:  Neuropsychopharmacology       Date:  2013-08-19       Impact factor: 7.853

6.  Allethrin differentially modulates voltage-gated calcium channel subtypes in rat PC12 cells.

Authors:  April P Neal; Yukun Yuan; William D Atchison
Journal:  Toxicol Sci       Date:  2010-05-13       Impact factor: 4.849

7.  The abused inhalant toluene differentially modulates excitatory and inhibitory synaptic transmission in deep-layer neurons of the medial prefrontal cortex.

Authors:  Jacob T Beckley; John J Woodward
Journal:  Neuropsychopharmacology       Date:  2011-03-23       Impact factor: 7.853

8.  Preclinical characterization of toluene as a non-classical hallucinogen drug in rats: participation of 5-HT, dopamine and glutamate systems.

Authors:  María Teresa Rivera-García; Carolina López-Rubalcava; Silvia L Cruz
Journal:  Psychopharmacology (Berl)       Date:  2015-08-09       Impact factor: 4.530

9.  Inhibition of cardiac sodium currents by toluene exposure.

Authors:  Silvia L Cruz; Gerardo Orta-Salazar; Marcia Y Gauthereau; Lourdes Millan-Perez Peña; Eduardo M Salinas-Stefanón
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.